Hyojin K

California . San Francisco - United States

Hyojin K 的邮箱和电话

电子邮件 ema***@***.com

Hyojin K 当前工作场所

Sutro Biopharma, Inc.

Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics. Sutro's proprietary and integrated cell-free protein synthesis platform XpressCF® and site-specific conjugation platform XpressCF+™ led to the discovery of STRO-001 and STRO-002, Sutro's first two internally-developed ADCs. STRO-001 is a CD74-targeting ADC currently under investigation in a Phase 1 clinical trial for patients with advanced B-cell malignancies and was granted Orphan Drug Designation by the FDA for multiple myeloma. STRO-002, a folate receptor alpha (FolRα)-targeting ADC, is currently being investigated in a Phase 1 clinical trial for patients with ovarian and endometrial cancers and was granted Fast Track designation by the FDA for ovarian cancer. A third product candidate, CC-99712, a BCMA- targeting ADC, which is part of Sutro's collaboration with Bristol Myers Squibb, formerly Celgene Corporation, is enrolling patients for its Phase 1 clinical trial of patients with multiple myeloma and has received Orphan Drug Designation from the FDA. A fourth product candidate, M1231, a MUC1-EGFR, bispecific ADC, which is part of Sutro's collaboration with Merck KGaA, Darmstadt, Germany, known as EMD Serono in the U.S. and Canada (EMD Serono), is enrolling patients for its Phase 1 clinical trial of patients with metastatic solid tumors, non-small cell lung cancer (NSCLC) and esophageal squamous cell carcinoma. These four product candidates resulted from Sutro's XpressCF® and XpressCF+™ technology platforms. Bristol Myers Squibb and EMD Serono have worldwide development and commercialization rights for CC-99712 and M1231, respectively, for which Sutro is entitled to milestone or contingent payments and tiered royalties. Sutro is dedicated to transforming the lives of cancer patients.

Hyojin K 简介

公司 Sutro Biopharma, Inc.
职位 Associate Director
地点 United States
LinkedIn
部门
头衔 Associate Director

Hyojin K 的常见问题(FAQs)

Hyojin K 在哪家公司工作?

Hyojin K 在 Sutro Biopharma, Inc. 担任 Associate Director

Hyojin K 在 Sutro Biopharma, Inc. 的职位是什么?

Hyojin K 在 Sutro Biopharma, Inc. 的职位是 Associate Director

Hyojin K 的电子邮件地址是什么?

Hyojin K 的电子邮件地址是 ema***@***.com

Hyojin K 的电话号码是什么?

Hyojin K 的电话号码是 -

Hyojin K 的工作电话号码是什么?

Hyojin K 的公司电话号码是 +165****

Hyojin K 从事哪个行业?

Hyojin K 在 research 工作。

Hyojin K 的同事是谁?

Hyojin K 的一些同事包括Nhung N、Andrew M、Jim A、Rajandeep BAnton K、。

我如何联系 Hyojin K?

Hyojin K联系方式: 电子邮件地址:ema***@***.com 电话号码:-

Hyojin K 的个人领英是多少

Hyojin K 的个人领英是:

Hyojin K 的办公地点在哪里?

Hyojin K 的办公地点:111 oyster point boulevard, south san francisco, california, united states

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展销采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google